Kyowa Kirin, Eli Lilly, Kura Oncology, and others are forming a new company to focus on menin inhibitors for disease, involving investment and shared operational teams.
1 report, 1 independent
Updated Sep 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kyowa Kirin, Eli Lilly, Kura Oncology, and others are forming a new company to focus on menin inhibitors for disease, involving investment and shared operational teams.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Kyowa Kirin
pharmaceutical company
-
Eli Lilly and Company
American pharmaceutical company